How many PHAXIAM Therapeutics shares are in issue?
PHAXIAM Therapeutics has 30,989,584 shares in issue.
What is the market cap of PHAXIAM Therapeutics?
The market capitalisation of PHAXIAM Therapeutics is EUR 49.09 M.
What is the 1 year trading range for PHAXIAM Therapeutics share price?
PHAXIAM Therapeutics has traded in the range of 1.50 € to 5.00 € during the past year.
What is the PE ratio of PHAXIAM Therapeutics?
The price to earnings ratio of PHAXIAM Therapeutics is -2.23.
What is the cash to sales ratio of PHAXIAM Therapeutics?
The cash to sales ratio of PHAXIAM Therapeutics is 39.49.
What is the reporting currency for PHAXIAM Therapeutics?
PHAXIAM Therapeutics reports financial results in EUR.
What is the latest annual turnover for PHAXIAM Therapeutics?
The latest annual turnover of PHAXIAM Therapeutics is EUR 1.33M.
What is the latest annual profit for PHAXIAM Therapeutics?
The latest annual profit of PHAXIAM Therapeutics is EUR -23.49M.
What is the registered address of PHAXIAM Therapeutics?
The registered address for PHAXIAM Therapeutics is 60 AVENUE ROCKEFELLER, LYON, RHONE, 69008.
What is the PHAXIAM Therapeutics website address?
The website address for PHAXIAM Therapeutics is www.phaxiam.com.
Which industry sector does PHAXIAM Therapeutics operate in?
PHAXIAM Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Hot Features
Premium
